Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 25, 2009
A2A adenosine receptor overexpression and functionality, as well as TNF-alpha levels, correlate with motor symptoms in Parkinson's diseaseKatia Varani, Fabrizio Vincenzi, Alice Tosi, et al.EJNMMI Research|August 20, 2017
Revisiting the Logan plot to account for non-negligible blood volume in brain tissueMartin Schain, Patrik Fazio, Ladislav Mrzljak, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 21, 2015
In Vivo and In Vitro Characterization of a Novel MAO-B Inhibitor Radioligand, 18F-Labeled Deuterated FluorodeprenylSangram Nag, Patrik Fazio, Lutz Lehmann, et al.Neuroimage|March 4, 2017
Patterns of age related changes for phosphodiesterase type-10A in comparison with dopamine D<sub>2/3</sub> receptors and sub-cortical volumes in the human basal ganglia: A PET study with <sup>18</sup>F-MNI-659 and <sup>11</sup>C-raclopride with correction for partial volume effectPatrik Fazio, Martin Schain, Ladislav Mrzljak, et al.Neuropharmacology|January 26, 2017
In vivo measurement of PDE10A enzyme occupancy by positron emission tomography (PET) following single oral dose administration of PF-02545920 in healthy male subjectsMarielle Delnomdedieu, Anton Forsberg, Adam Ogden, et al.European Journal of Nuclear Medicine and Molecular Imaging|September 17, 2016
Positron emission tomography measurement of brain MAO-B inhibition in patients with Alzheimer's disease and elderly controls after oral administration of sembragilineStefan Sturm, Anton Forsberg, Stephane Nave, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 23, 2020
PET Molecular Imaging of Phosphodiesterase 10A: An Early Biomarker of Huntington's Disease ProgressionPatrik Fazio, Cheryl J Fitzer-Attas, Ladislav Mrzljak, et al.Journal of Internal Medicine|July 8, 2024
Spinocerebellar ataxia type 4 is caused by a GGC expansion in the ZFHX3 gene and is associated with prominent dysautonomia and motor neuron signsMartin Paucar, Daniel Nilsson, Martin Engvall, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|September 27, 2022
Quantification of the purinergic P2X<sub>7</sub> receptor with [<sup>11</sup>C]SMW139 improves through correction for brain-penetrating radiometabolitesJoachim Brumberg, Richard Aarnio, Anton Forsberg, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 7, 2025
Imaging Proinflammatory Microglia in Parkinson Disease Using [<sup>11</sup>C]SMW139 PET: A Multicenter StudyRoos M Rikken, Elsmarieke van de Giessen, Joachim Brumberg, et al.Pageof 4